Hester Biosciences Limited (NSE:HESTERBIO)
India · Delayed Price · Currency is INR 1,419.40
+53.80 (3.94%)
Apr 2, 2026, 3:29 PM IST
Hester Biosciences Market Cap
Hester Biosciences has a market cap or net worth of 12.15 billion as of April 2, 2026. Its market cap has increased by 7.31% in one year.
Market Cap
12.15B
Enterprise Value
14.33B
Revenue
3.16B
Ranking
n/a
PE Ratio
29.67
Stock Price
1,419.40
Market Cap Chart
Since October 11, 1996, Hester Biosciences's market cap has increased from 22.04M to 12.15B, an increase of 55,000.72%. That is a compound annual growth rate of 23.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 12.15B | -10.30% |
| Dec 31, 2025 | 13.54B | -33.49% |
| Dec 31, 2024 | 20.36B | 64.06% |
| Dec 29, 2023 | 12.41B | -18.54% |
| Dec 30, 2022 | 15.24B | -29.34% |
| Dec 31, 2021 | 21.56B | 48.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharma Advanced Research Company | 40.26B |
| RPG Life Sciences | 31.77B |
| Orchid Pharma | 26.57B |
| Solara Active Pharma Sciences | 22.93B |
| Indoco Remedies | 17.29B |
| Windlas Biotech | 16.11B |
| Beta Drugs | 14.00B |
| Jagsonpal Pharmaceuticals | 12.47B |